BSECompany Update6d ago · 12 Nov 2026, 03:03 pm

Intimation of schedule of Analysts/ Investors Earning Call for the Ouarter-II of F.Y. 2026-27 ended on September 30, 2026

Orchid Pharma Ltd · 524372

✦ AI SummaryResults

Orchid Pharma Ltd has announced the schedule of Analysts/Investors Earning Call for the Quarter-II of F.Y. 2026-27 ended on September 30, 2026, to be held on November 17, 2026, at 4:30 P.M. to discuss the financial performance/financial results of the Company.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

d2fa1ff7-fae1-4306-8c74-b5f937d95461.pdf

pdf

Download →
View document text
OrchidPharm~W -- A Dhanuka Group Company ---------------:..------------------------ November 12, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai- 400051 Dalal Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulations, 2015 (ii) SEBI Master Circular No. SEBI/HO/49/14/14(7}2025-CFDPOD21 I/3762/2026 dated January 30, 2026 Sub: Intimation of schedule of Analystsl Investors Earning Call for the Ouarter-II of F.Y. 2026-27 ended on September 30, 2026 Dear Sir/Madam, In reference to the captioned subject and pursuant to Regulation 30 read with Sub-Para 15, Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular No. SEBI/HOj49j14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 and in .continuation to our intimation dated November 11, 2026 regarding intimation of schedule of Board Meeting, this is to intimate that an Analysts/Investors Earning Call hosted by 'Systematix Institutional Equities' is scheduled to be held on Tuesday, November 17, 2026 at 4: 30 P.M. (1ST) to discuss the financial performance/ financial results of the Company for the Quarter-II and half year ended on September 30, 2026. The aforesaid information will also be hosted on the Company's website at www.orchidpharma.com .Note: The schedule may undergo change due to exigencies on the part of the Analysts/Investors/Company. The invite of the Analysts/Investors Earnings Call is enclosed herewith. You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited Kapil Oayya Company Secretary & Compliance Officer Mem. No. F10698 Encl.,' as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.